C52 -Malignant neoplasm of vagina
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C52 – N =1,703
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 27.4% | 16.1% | 17.7% | 16.1% | 22.6% | 62 |
1983 | 35.8% | 11.3% | 20.8% | 11.3% | 20.8% | 53 |
1984 | 18.8% | 21.7% | 18.8% | 21.7% | 18.8% | 69 |
1985 | 25% | 25% | 16.1% | 14.3% | 19.6% | 56 |
1986 | 25.4% | 13.6% | 13.6% | 27.1% | 20.3% | 59 |
1987 | 36.7% | 20.4% | 2% | 8.2% | 32.7% | 49 |
1988 | 22.9% | 20.8% | 14.6% | 6.3% | 35.4% | 48 |
1989 | 24.6% | 18.8% | 15.9% | 14.5% | 26.1% | 69 |
1990 | 24.7% | 20.5% | 11% | 5.5% | 38.4% | 73 |
1991 | 31.3% | 18.8% | 12.5% | 4.2% | 33.3% | 48 |
1992 | 27.3% | 14.5% | 12.7% | 7.3% | 38.2% | 55 |
1993 | 22% | 18.6% | 15.3% | 10.2% | 33.9% | 59 |
1994 | 32.5% | 15% | 15% | 7.5% | 30% | 40 |
1995 | 35.1% | 13.5% | 16.2% | 8.1% | 27% | 37 |
1996 | 32.4% | 10.8% | 13.5% | 16.2% | 27% | 37 |
1997 | 19.5% | 12.2% | 12.2% | 22% | 34.1% | 41 |
1998 | 29.3% | 19.5% | 9.8% | 12.2% | 29.3% | 41 |
1999 | 29.2% | 16.7% | 4.2% | 6.3% | 43.8% | 48 |
2000 | 27.7% | 14.9% | 19.1% | 8.5% | 29.8% | 47 |
2001 | 15.6% | 24.4% | 15.6% | 6.7% | 37.8% | 45 |
2002 | 31% | 17.2% | 8.6% | 12.1% | 31% | 58 |
2003 | 25% | 25% | 13.9% | 11.1% | 25% | 36 |
2004 | 29.6% | 16.7% | 20.4% | 11.1% | 22.2% | 54 |
2005 | 34% | 14.9% | 14.9% | 17% | 19.1% | 47 |
2006 | 25.9% | 20.7% | 12.1% | 10.3% | 31% | 58 |
2007 | 39.6% | 11.3% | 11.3% | 15.1% | 22.6% | 53 |
2008 | 31.4% | 17.6% | 23.5% | 13.7% | 13.7% | 51 |
2009 | 30.4% | 15.2% | 10.9% | 26.1% | 17.4% | 46 |
2010 | 14% | 20% | 18% | 34% | 14% | 50 |
2011 | 28.3% | 21.7% | 17.4% | 15.2% | 17.4% | 46 |
2012 | 28% | 20% | 20% | 10% | 22% | 50 |
2013 | 25.5% | 18.2% | 18.2% | 10.9% | 27.3% | 55 |
2014 | 33.3% | 20.6% | 12.7% | 9.5% | 23.8% | 63 |